(Q34537257)

English

Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Hilda Wong

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Silvia Lau

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Polly Cheung

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Ting Ting Wong

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Andrew Parker

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Richard J Epstein

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

0 references

publication date

10 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

826

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

The relationships between snail1 and estrogen receptor signaling in breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expressi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Different roles of estrogen receptors alpha and beta in the regulation of E-cadherin protein levels in a mouse mammary epithelial cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer--a retrospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Is drug-induced toxicity a good predictor of response to neo-adjuvant chemotherapy in patients with breast cancer?--a prospective clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Correlation of Snail expression with histological grade and lymph node status in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Frequent loss of alpha catenin expression in scirrhous carcinomas with scattered cell growth.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Immunohistochemical demonstration of cell proliferation and estrogen receptor status in human breast cancer. Analysis of 45 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

7 July 2018

Trends in incidence rates of invasive lobular and ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Outcome of special types of luminal breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Invasive lobular vs. ductal breast cancer: a stage-matched comparison of outcomes

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Association of increased estrogen receptor beta2 expression with parity-induced alterations in the rat mammary gland

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Snail and slug play distinct roles during breast carcinoma progression.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Genomic grade adds prognostic value in invasive lobular carcinoma.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-14-826

21 January 2018

Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

27 October 2018

Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

27 October 2018

Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4236427

27 October 2018

Comparative validation of the SP6 antibody to Ki67 in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of mortality by histologic type of breast cancer in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radial intratumoral increase and correlation of microvessels and proliferation in solid breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wide metastatic spreading in infiltrating lobular carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinicopathological correlates in a cohort of Hong Kong breast cancer patients presenting with screen-detected or symptomatic disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility

1 reference

https://pubmed.ncbi.nlm.nih.gov/25385074

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-14-826

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25385074%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34537257&oldid=2196749540"